Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol

Glucocorticoids (GCs) are a central component of multi-drug treatment protocols against T and B acute lymphoblastic leukemia (ALL), which are used intensively during the remission induction to rapidly eliminate the leukemic blasts. The primary response to GCs predicts the overall response to treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Olivas-Aguirre, Miguel, Torres-López, Liliana, Pottosin, Igor, Dobrovinskaya, Oxana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991804/
https://www.ncbi.nlm.nih.gov/pubmed/33777761
http://dx.doi.org/10.3389/fonc.2021.617937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991804/
https://www.ncbi.nlm.nih.gov/pubmed/33777761
http://dx.doi.org/10.3389/fonc.2021.617937

Ejemplares similares